Published in Circulation on October 01, 1991
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Optimal antiarrhythmic drug therapy for electrical storm. J Biomed Res (2015) 0.82
Torsades de Pointes. Curr Treat Options Cardiovasc Med (1999) 0.76
Polymorphous ventricular tachycardia associated with acute myocardial infarction. Circulation (1992) 0.75
Prevalence and prognostic significance of long QT interval among patients with chest pain: selecting an optimum QT rate correction formula. J Electrocardiol (2013) 0.75
Mode of onset of polymorphic ventricular tachycardia in acute myocardial infarction. Can J Cardiol (2010) 0.75
Anesthetic Management in Radiofrequency Catheter Ablation of Ventricular Tachycardia. Tex Heart Inst J (2016) 0.75
The classical "R-on-T" phenomenon. Indian Heart J (2015) 0.75
Cardiological Society of India: Position statement for the management of ST elevation myocardial infarction in India. Indian Heart J (2017) 0.75
Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med (1973) 2.79
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol (1999) 2.58
Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev (1999) 2.57
Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res (2003) 2.12
Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation (1973) 2.08
Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor. Circulation (1980) 2.02
Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem (2003) 1.97
Electrocardiographic changes subsequent to artificial ventricular depolarization. Br Heart J (1969) 1.88
Vasodilator treatment for acute and chronic heart failure. Br Heart J (1977) 1.84
Heart-block following acute myocardial infarction. Treatment with demand and fixed-rate pacemakers. Lancet (1968) 1.77
Comparison of transesophageal echocardiographic and scintigraphic estimates of left ventricular end-diastolic volume index and ejection fraction in patients following coronary artery bypass grafting. Anesthesiology (1990) 1.75
Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol (2000) 1.73
Metabolic and hemodynamic consequences of sodium bicarbonate administration in patients with heart disease. Am J Med (1989) 1.70
The role of vasodilator therapy in heart failure. Prog Cardiovasc Dis (1977) 1.69
Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate. J Am Coll Cardiol (1994) 1.66
Heart failure therapy in evolution. Circulation (1996) 1.64
The influence of left ventricular filling pressure on atrial contribution to cardiac output. Am Heart J (1979) 1.63
Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med (1980) 1.63
Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure. Am Heart J (1975) 1.58
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Detection and characterization of acute myocardial infarction in man with use of gated magnetic resonance. Circulation (1985) 1.55
Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study. Circulation (1982) 1.54
The risk of pacing after infarction, and current recommendations. Lancet (1969) 1.50
Combined coronary artery bypass grafting and abdominal aortic aneurysm repair. Am J Surg (1998) 1.49
Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts). N Engl J Med (1976) 1.45
Markers for transfusion-transmissible infections in north Indian voluntary and replacement blood donors: prevalence and trends 1989-1996. Vox Sang (1997) 1.44
Testosterone relaxes rabbit coronary arteries and aorta. Circulation (1995) 1.42
Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle. Am Heart J (1990) 1.40
The noninvasive diagnosis of right ventricular infarction. Circulation (1978) 1.39
Effects of vasodilator therapy for severe pump failure in acute myocardial infarction on short-term and late prognosis. Circulation (1976) 1.37
Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation (1973) 1.36
Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements. Circulation (1981) 1.35
Optimal level of filling pressure in the left side of the heart in acute myocardial infarction. N Engl J Med (1973) 1.32
Oral hydralazine therapy for chronic refractory heart failure. Circulation (1976) 1.30
Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group. J Am Coll Cardiol (1999) 1.30
Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation (1996) 1.30
Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts). N Engl J Med (1976) 1.28
Depression of left ventricular function due to acute myocardial ischemia and its reversal after aortocoronary saphenous-vein bypass. N Engl J Med (1972) 1.27
The cavity electrocardiogram in emergency artificial pacing. Postgrad Med J (1969) 1.27
Emergency bypass surgery in impending and complicated acute myocardial infarction. Arch Surg (1972) 1.27
Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction. Circulation (1973) 1.26
Fall of endocardial potentials after acute myocardial infarction. Lancet (1970) 1.26
Percutaneous radiofrequency catheter ablation for supraventricular arrhythmias in children. J Am Coll Cardiol (1991) 1.26
Closed-chest electrode-catheter technique for His bundle ablation in dogs. Am J Physiol (1981) 1.24
In vivo morphometry of the lamina cribrosa and its relation to visual field loss in glaucoma. Curr Eye Res (1998) 1.23
Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure. J Am Coll Cardiol (1983) 1.18
Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Am J Cardiol (1977) 1.16
Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations. J Am Coll Cardiol (1983) 1.14
Pericardial effusion associated with minoxidil therapy. Arch Intern Med (1981) 1.14
Choroidal hypoperfusion in acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiography study. Ophthalmology (1995) 1.13
Ventricular endocardial potentials after experimental coronary artery occlusion in dogs. Am Heart J (1971) 1.13
Rationale and limitations of hemodynamic measurements in patients with acute myocardial infarction. Mod Concepts Cardiovasc Dis (1969) 1.12
Low intracardiac potentials in myocardial infarction as a cause of failure of inhibition of demand pacemakers. Lancet (1968) 1.11
Assessment of left ventricular function by single plane cineangiographic volume analysis. Br Heart J (1971) 1.10
Coronary sinus reflux. A source of error in the measurement of thermodilution coronary sinus flow. Circulation (1978) 1.10
Hemodynamic spectrum of myocardial infarction and cardiogenic shock. A conceptual model. Circulation (1972) 1.09
Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure. Am J Cardiol (1979) 1.09
Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. J Am Coll Cardiol (1995) 1.08
Carcinoid heart disease from primary ovarian carcinoid tumors. A case report and review of the literature. Am J Med (1968) 1.08
Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy. J Am Coll Cardiol (1992) 1.08
The role of right ventricular systolic dysfunction and elevated intrapericardial pressure in the genesis of low output in experimental right ventricular infarction. Circulation (1982) 1.08
Hemodynamic effects of nitroglycerin ointment in congestive heart failure. Am J Cardiol (1976) 1.06
Nucleic acid testing for blood banks: an experience from a tertiary care centre in New Delhi, India. Transfus Apher Sci (2013) 1.06
The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma. Eur J Endocrinol (2007) 1.05
Vasodilator therapy. Curr Probl Cardiol (1978) 1.05
The IGSF1 deficiency syndrome: characteristics of male and female patients. J Clin Endocrinol Metab (2013) 1.05
Thallium-201 myocardial perfusion scintigraphy to evaluate patients after coronary bypass surgery. Am J Cardiol (1978) 1.04
Impact of a home-based walking and resistance training program on quality of life in patients with heart failure. Am J Cardiol (2000) 1.03
Vasodilator therapy for chronic heart failure. Annu Rev Pharmacol Toxicol (1980) 1.02
Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation (1997) 1.02
Relationship between pulmonary artery end-diastolic pressure and left ventricular filling pressure in patients in shock. Circulation (1973) 1.02
Clinical and anatomic implications of intraventricular conduction blocks in acute myocardial infarction. Circulation (1972) 1.01
The phase image: its relationship to patterns of contraction and conduction. Circulation (1982) 1.00
Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities. Am J Med (1985) 1.00
Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet (1997) 1.00
State of maternal, newborn and child health programmes in Nepal: what may a continuum of care model mean for more effective and efficient service delivery? J Nepal Health Res Counc (2011) 0.99
Attenuation of prazosin effect on cardiac output in chronic heart failure. Ann Intern Med (1979) 0.99
In-utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats. J Am Coll Cardiol (1998) 0.98
Beneficial effects of hydralazine in severe mitral regurgitation. Circulation (1978) 0.98
A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J Clin Endocrinol Metab (2005) 0.98
T-wave changes after artificial pacing. Lancet (1969) 0.97
Influence of atrial systole on the Frank-Starling relation and the end-diastolic pressure-diameter relation of the left ventricle. Circulation (1983) 0.97
Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing. J Am Coll Cardiol (1983) 0.97
Volume loading improves low cardiac output in experimental right ventricular infarction. J Am Coll Cardiol (1983) 0.97
Physiological concentrations of estradiol attenuate endothelin 1-induced coronary vasoconstriction in vivo. Circulation (1997) 0.97
Segment stroke work and metabolism depend on coronary blood flow in the pig. Am J Physiol (1978) 0.96
Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. Am J Cardiol (1983) 0.96
Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity. Circulation (1986) 0.96
Decreased coronary sinus oxygen content: a predictor of adverse prognosis in patients with severe congestive heart failure. J Am Coll Cardiol (1991) 0.96
Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure. Am J Cardiol (1984) 0.96
Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy. Am Heart J (1988) 0.95
An accurate means of detecting and characterizing abnormal patterns of ventricular activation by phase image analysis. Am J Cardiol (1982) 0.95
Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure. J Am Coll Cardiol (1987) 0.95
Measurement of associated production of vector bosons and top quark-antiquark pairs in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2013) 0.95
The electrocardiogram in chronic heart block. A histological correlation with ECG changes in 42 patients. Am Heart J (1970) 0.94
Case report: clinical findings and successful resection of melanoma metastatic to the right atrium. Cancer Invest (1994) 0.94
Selective catheter ablation of the tachycardia focus in patients with nonreentrant junctional tachycardia. Am J Cardiol (1996) 0.94
Parotid gland cysticercosis. J Assoc Physicians India (2007) 0.93
Rate-pressure product and myocardial oxygen consumption during surgery for coronary artery bypass. Circulation (1979) 0.93